Filoviruses, including Ebola virus, pose an increasing threat to the public health. Although
two therapeutic monoclonal antibodies have been approved to treat the Ebola virus …

Summary Background The recent Sudan virus (SUDV) outbreak in Uganda highlights the
need for rapid response capabilities, including development of vaccines against emerging …

Long non-coding RNAs (lncRNAs) are involved in numerous biological processes and are
pivotal mediators of the immune response, yet little is known about their properties at the …

Viral infections can cause rampant disease in human beings, ranging from mild to acute, that
can often be fatal unless resolved. An acute viral infection is characterized by sudden or …

Virus infection has been one of the main causes of human death since the ancient times.
Even though more and more antiviral drugs have been approved in clinic, long-term use can …

The emergence of highly pathogenic and deadly human coronaviruses, namely SARS-CoV
and MERS-CoV within the past two decades and currently SARS-CoV-2, have resulted in …

Abstract On April 23, 2022, the Ministry of Health of the Democratic Republic of the Congo
announced an EVD outbreak after discovering 2 confirmed cases and identifying 267 …

Ebola virus is among the most dangerous, contagious and deadly etiological causes of viral
diseases. However, Ebola virus has never extensively spread in human population and …

Effective therapeutics have been developed against acute Ebola virus disease (EVD) in both
humans and experimentally infected nonhuman primates. However, the risk of viral …

Marburg and Ebola filoviruses are two of the deadliest infectious agents and several
outbreaks have occurred in the last decades. Although several receptors and co-receptors …